Summary $Tempus AI(TEM)$ is a leading player in healthcare AI, aiming to deliver personalized treatment suggestions through its proprietary data model.Preliminary Q4 results and 2025 guidance show mixed performance, with revenue slightly below expectations but positive adjusted EBITDA anticipated for 2025, driven by the Ambry Genetics acquisition.TEM's strong fundamentals and competitive position, bolstered by the Ambry acquisition, support long-term growth, particularly in diagnostics and expanding AI applications across healthcare.Despite valuation concerns and potential competition, TEM's multi-year growth drivers and AI advancements offer significant long-term investment potential for patient investors.Monty Rakusen

According to the latest news, it is still uncertain whether Trump will buy TikTok. Here are the relevant dynamics:Trump's attitude towards TikTokIn a recent speech, Trump said that he was in favor of TikTok continuing to operate in the United States for a period of time, and said that he "had a good impression of TikTok" because he gained a lot of support from young people through TikTok in the general election. In addition, Trump also expressed his hope that the United States would have 50% ownership in future joint ventures.TikTok's operationTikTok resumed its services in the United States on January 19. Trump plans to issue an executive order on January 20 to extend the effective time of the TikTok ban in order to find a solution.Possibility of acquisitionAt present, Trump has not expli

$NVIDIA(NVDA)$ down 6% as highly skewed call options unwound after the anticipated recent keynote speech from the company’s CEO. $Aurora Innovation(AUR)$ up 29% after the company announced a partnership with $NVDA, with Nvidia’s DRIVE Thor and DriveOS to be integrated into the Aurora Driver. $Rigetti Computing(RGTI)$ $IONQ Inc.(IONQ)$ down 5% and 3% respectively after $NVDA’s CEO made comments on quantum computing, stating it will take many years to come to fruition. $Palantir Technologies Inc.(PLTR)$ down 7% as a sell-off sustained following Morgan Stanley’s downgrade of the

Berkshire Hathaway $Berkshire Hathaway(BRK.B)$ $Berkshire Hathaway(BRK.A)$ is back at it — purchasing 20,044 more shares of $VeriSign(VRSN)$ for $4.1 million over the past three days.Berkshire Hathaway disclosed that from Dec 20 2024 through Jan 3 2025, All in all, Berkshire has now bought $VRSN stock on 12 consecutive trading days.Source: SEC.GOVBerkshire purchased $VeriSign(VRSN)$ at an average price of $204.71, Warren Buffett now owns 13% of Verisign! Below are the current stock trend of $VeriSign(VRSN)$. $VeriSign(VRSN)$ owns the

$Palantir Technologies Inc.(PLTR)$ Most recent quotes from CEO Alex Karp "The reason I am so bullish on our company and yours and actually our nation right now is what makes Palantir internally and organizationally so special.... is that we are constantly focused on what is the core principles that an enterprise should be." "So the government has one customer, you know it's one buyer and typically go to the government and then they just you know the government say build me a space machine, tell me I am smart and everyone says Yes. The space machine is coming $2B dollars and you are smart. And Palantir is like "we are not doing that" we are building a product you should have. Not the product you've asked for... money for the product you should have

1. $Hims & Hers Health Inc.(HIMS)$ can easily become a $100 billion company in the next decade. It's revolutionizing the telemedicine market by offering customized drugs for each patient. Here is everything you need to know about $HIMS, business, investment thesis, financials, everything. Image2. Many people get $Hims & Hers Health Inc.(HIMS)$ wrong. It's not a direct-to-consumer (D2C) generic drug provider. Its business provides patients with primary care visit for just $39. It then prescribes and fulfills the treatment with an option to personalize the treatment for each patient.Image3. $HIMS saw its revenues explode. Revenues grew at 70% CAGR in the last 5 years, validating the business model.

The stock market will be closed on Thursday for Thanksgiving, and only be open between 9.30 a.m. and 1 p.m. Eastern Time on Black Friday.History suggests there could be some gains for equities between now and Nov. 28.Historical Market performanceThe $.SPX(.SPX)$ has risen 69% of the time in Thanksgiving week since 1950, according to Dow Jones Market Data. The benchmark gauge has climbed 0.7% on average.From 2001 through 2023, the $.SPX(.SPX)$ 's overall performance around the Thanksgiving holiday has been mixed, seeing positive returns just half the time. Over that time, the $.SPX(.SPX)$ had more than 1% gains on just three Black Fridays—in 2001, 2007, and 2012—b

1. $Palantir Technologies Inc.(PLTR)$ announced its decision to transfer its Class A Common Stock listing from the New York Stock Exchange to the Nasdaq Global Select Market. The company will maintain its ticker symbol 'PLTR' and expects to commence trading on Nasdaq on November 26, 2024. Palantir anticipates meeting the eligibility requirements for inclusion in the Nasdaq-100 Index.This gives them the potential to be added to one of the world's most popular tech-focused ETFs, the Nasdaq $Invesco QQQ(QQQ)$ . $Invesco QQQ(QQQ)$ has $318B in AUM. This year alone, they were the 4th largest ETF in terms of inflow with +27.8B added.